228 related articles for article (PubMed ID: 11520721)
1. The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands.
Feenstra TL; van Genugten ML; Hoogenveen RT; Wouters EF; Rutten-van Mölken MP
Am J Respir Crit Care Med; 2001 Aug; 164(4):590-6. PubMed ID: 11520721
[TBL] [Abstract][Full Text] [Related]
2. A dynamic population model of disease progression in COPD.
Hoogendoorn M; Rutten-van Mölken MP; Hoogenveen RT; van Genugten ML; Buist AS; Wouters EF; Feenstra TL
Eur Respir J; 2005 Aug; 26(2):223-33. PubMed ID: 16055869
[TBL] [Abstract][Full Text] [Related]
3. Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands.
Rutten-van Mölken MP; Postma MJ; Joore MA; Van Genugten ML; Leidl R; Jager JC
Respir Med; 1999 Nov; 93(11):779-87. PubMed ID: 10603626
[TBL] [Abstract][Full Text] [Related]
4. The global impact of noncommunicable diseases: estimates and projections.
Manton KG
World Health Stat Q; 1988; 41(3-4):255-66. PubMed ID: 3232413
[TBL] [Abstract][Full Text] [Related]
5. A review of population studies from India to estimate national burden of chronic obstructive pulmonary disease and its association with smoking.
Jindal SK; Aggarwal AN; Gupta D
Indian J Chest Dis Allied Sci; 2001; 43(3):139-47. PubMed ID: 11529432
[TBL] [Abstract][Full Text] [Related]
6. The epidemiology of cigarette smoking and its impact on chronic obstructive pulmonary disease.
Davis RM; Novotny TE
Am Rev Respir Dis; 1989 Sep; 140(3 Pt 2):S82-4. PubMed ID: 2782765
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands.
Vanfleteren LE; Franssen FM; Wesseling G; Wouters EF
Respir Med; 2012 Jun; 106(6):871-4. PubMed ID: 22349067
[TBL] [Abstract][Full Text] [Related]
8. Developing and applying a stochastic dynamic population model for chronic obstructive pulmonary disease.
Hoogendoorn M; Rutten-van Mölken MP; Hoogenveen RT; Al MJ; Feenstra TL
Value Health; 2011 Dec; 14(8):1039-47. PubMed ID: 22152172
[TBL] [Abstract][Full Text] [Related]
9. Changes in the prevalence of chronic disease and the association with disability in the older Dutch population between 1987 and 2001.
Puts MT; Deeg DJ; Hoeymans N; Nusselder WJ; Schellevis FG
Age Ageing; 2008 Mar; 37(2):187-93. PubMed ID: 18250095
[TBL] [Abstract][Full Text] [Related]
10. Disease and injury in California with projections to the year 2007. Implications for medical education.
Ragland DR; Buffler PA; Reingold AL; Syme SL; Buffler ML
West J Med; 1998 May; 168(5):378-99. PubMed ID: 9614796
[TBL] [Abstract][Full Text] [Related]
11. [Morbidity, mortality and the potential years of life lost attributable to tobacco].
Rodríguez Tapioles R; Bueno Cavanillas A; Pueyos Sánchez A; Espigares García M; Martínez González MA; Gálvez Vargas R
Med Clin (Barc); 1997 Feb; 108(4):121-7. PubMed ID: 9162780
[TBL] [Abstract][Full Text] [Related]
12. Relative contribution of various chronic diseases and multi-morbidity to potential disability among Dutch elderly.
Botes R; Vermeulen KM; Correia J; Buskens E; Janssen F
BMC Health Serv Res; 2018 Jan; 18(1):24. PubMed ID: 29334922
[TBL] [Abstract][Full Text] [Related]
13. Burden of disease due to cutaneous melanoma has increased in the Netherlands since 1991.
Holterhues C; Hollestein LM; Nijsten T; Koomen ER; Nusselder W; de Vries E
Br J Dermatol; 2013 Aug; 169(2):389-97. PubMed ID: 23551191
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of chronic obstructive pulmonary disease (COPD).
Viegi G; Scognamiglio A; Baldacci S; Pistelli F; Carrozzi L
Respiration; 2001; 68(1):4-19. PubMed ID: 11223724
[TBL] [Abstract][Full Text] [Related]
15. Global perspective on tobacco control. Part I. The global state of the tobacco epidemic.
Slama K
Int J Tuberc Lung Dis; 2008 Jan; 12(1):3-7. PubMed ID: 18173869
[TBL] [Abstract][Full Text] [Related]
16. The burden of asthma and chronic obstructive pulmonary disease: data from The Netherlands.
Rutten van-Mölken MP; Feenstra TL
Pharmacoeconomics; 2001; 19 Suppl 2():1-6. PubMed ID: 11700783
[TBL] [Abstract][Full Text] [Related]
17. COPD in the general population: prevalence, incidence and survival.
Afonso AS; Verhamme KM; Sturkenboom MC; Brusselle GG
Respir Med; 2011 Dec; 105(12):1872-84. PubMed ID: 21852081
[TBL] [Abstract][Full Text] [Related]
18. Estimating the burden of disease attributable to smoking in South Africa in 2000.
Groenewald P; Vos T; Norman R; Laubscher R; van Walbeek C; Saloojee Y; Sitas F; Bradshaw D;
S Afr Med J; 2007 Aug; 97(8 Pt 2):674-81. PubMed ID: 17952224
[TBL] [Abstract][Full Text] [Related]
19. Active detection of chronic obstructive pulmonary disease and asthma in the general population. Results and economic consequences of the DIMCA program.
van den Boom G; van Schayck CP; van Möllen MP; Tirimanna PR; den Otter JJ; van Grunsven PM; Buitendijk MJ; van Herwaarden CL; van Weel C
Am J Respir Crit Care Med; 1998 Dec; 158(6):1730-8. PubMed ID: 9847260
[TBL] [Abstract][Full Text] [Related]
20. [The prevalence of chronic obstructive pulmonary disease (COPD) in Germany. Results of the BOLD study].
Geldmacher H; Biller H; Herbst A; Urbanski K; Allison M; Buist AS; Hohlfeld JM; Welte T
Dtsch Med Wochenschr; 2008 Dec; 133(50):2609-14. PubMed ID: 19052996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
